Search Count: 9
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: 799 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3W |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.68 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3R |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3N |
 |
Identification Of An Imidazopyridine Scaffold To Generate Potent And Selective Tyk2 Inhibitors That Demonstrate Activity In An In Vivo Psoriasis Model
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2017-09-06 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 9ZS |
 |
Identification Of An Imidazopyridine Scaffold To Generate Potent And Selective Tyk2 Inhibitors That Demonstrate Activity In An In Vivo Psoriasis Model
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2017-09-06 Classification: Transferase/Transferase Inhibitor Ligands: 9ZS |
 |
Chk1 Kinase Domain With Diazacarbazole Compound 8: N-[3-(6-Cyano-9H-Pyrrolo[2,3-B:5,4-C']Dipyridin-3-Yl)Phenyl]Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2015-06-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3XK |
 |
Chk1 Kinase Domain With Diazacarbazole Compound 7: 3-(2-Hydroxyphenyl)-9H-Pyrrolo[2,3-B:5,4-C']Dipyridine-6-Carbonitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2015-06-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3XL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2015-06-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3X7 |